Congresso EULAR 2023: AbbVie apresenta dados de longo prazo que confirmam perfil de eficácia e de segurança de upadacitinibe em diferentes doenças reumáticas ...Middle East

SÃO PAULO, 31 de maio de 2023 /PRNewswire/ -- A AbbVie (NYSE: ABBV) anunciou que serão apresentados novos dados de longo prazo que mostram o perfil de eficácia e de segurança de upadacitinibe, referentes aos estudos SELECT-COMPARE, SELECT-PsA 1 e SELECT-AXIS 2, durante o Congresso Europeu...

Hence then, the article about congresso eular 2023 abbvie apresenta dados de longo prazo que confirmam perfil de eficacia e de seguranca de upadacitinibe em diferentes doencas reumaticas was published today ( Wednesday 31/05/2023 - 04:24 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Congresso EULAR 2023: AbbVie apresenta dados de longo prazo que confirmam perfil de eficácia e de segurança de upadacitinibe em diferentes doenças reumáticas )

Also on site :

• One person in critical condition following two-vehicle collision on SR-126 at Boosey Road
• Supermarket timings for Boxing Day and New Year revealed for Asda, Tesco, Sainsbury’s, Aldi, Lidl and more
• Trump rants about Epstein in Christmas Day post claiming he dropped ties with sex offender ‘long before it became fashionable’